CSO I Chief Scientific Officer
Gorka Etxebarria Jardí obtained the BSc of Chemistry in 2004, MSc in Organic Chemistry in 2005 and PhD in Medicinal Chemistry in 2010, all from the University of Barcelona. During this time, he gained experience on Organic Chemistry, new methodologies and transformations for organic synthesis of natural products and he developed broad interest for molecules with bioactive properties and their use as pharmaceuticals.
In 2011 he joined Almirall where he worked as a Medicinal Chemistry Scientist in the lead optimization of inhaled drugs for treatment of asthma and chronic obstructive pulmonary disease. In 2012 he moved to Vertex Pharmaceuticals, Oxford (UK),where he worked as Medicinal Chemistry Scientist for 8 years. Gorka has been involved in a variety of preclinical hit identification/validation, hit-to-lead and lead optimization programs delivering several clinical candidates in cancer and pain therapeutic areas. His expertise ranges fromoptimization of Pharmaceutical and DMPK properties, fragment and structure-based drug design,target-ligand molecular interactions, drug discovery computational tools, biology of protein kinases and ion channels, competitive intelligence (patent analysis and data mining), amongst others.He has co-authored 9 publications in top tier peer-reviewed journals and is co-inventor of 5 international patent applications.
Gorkamoved back to Barcelona where he started his new role as NostrumBiodiscoveryChief Scientific Officer in June 2020.